| PRODUCT DESCRIPTION |
| TAZOBACTAM SODIUM + PIPERACILLIN SODIUMSTERILE (B.NO. TSP11009816 MFG: 11/16, EXP: 10/19) |
| CHEMICAL NOT COVERED UNDER SCOMET-OLANZAPINE-WE INTEND TO TAKE CHAPTER 3 BENIFIT |
| TAZOBACTAM SODIUM + PIPERACILLIN SODIUMSTERILE (B.NO. TSP11008716N MFG: 10/16,EXP: 09/19) |
| SAXAGLIPTIN HYDROCHLORIDE (SXI 6010 M.OCT-2016 E.SEP-2017) |
| TICAGRLOR - WE INTEND TO TAKE CHAPTER 3BENIFIT |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023316,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002022716,MFG.OCTOBER/2016,RE TEST DATE:SEPTEMBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023116,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002022616,MFG.OCTOBER/2016,RE TEST DATE:SEPTEMBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023016,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023216,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| MONTELUKAST SODIUM (MLT 6506 M.OCT-2016 E.SEP-2019) |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023616,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023416,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| ATORVASTATIN CALCIUM , BATCH NO.M110210DOM MAR-2016 DOE FEB-2020 |
| MONTELUKAST SODIUM (MKT 6579 M.OCT-2016 E.SEP-2019, MKT 6580 M.NOV-2016 E.OCT-2019) |
| FINE ORGANIC COMPOUND RESEARCH SAMPLETRM-01785 (ITEMS BEING SENT FOR FUTHERANALYSIS AND APPROVAL) |
| REFERENCE STANDARD & IMPURITEIS OF SAXAGLIPTIN MONOHYDRATE |
| INTERMEDIATE AND MOTHER LIQUOR OF SAXAGLIPTIN MONOHYDRATE |
| (1S,3S,5S)-2-[(2S)-2-AMINO-2-(3-HYDROTRICYCLO[3.3.1.13.7]DEC-1-YL)ACETYL]2-AZABICYCLO[3.1.0]HEXANE-3-CAARBONITRILE,MONOH |
| ATORVASTATIN CALCIUM , BATCH NO.M110243DOM APR-2016 DOE MAR-2020 |
| MIDAZOLAM PH.EUR (EP & COS) (IMPORT PERMIT NO: AI-388-2016, EXPORT PERMIT NO: P-EXP-12132/2016) |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023716,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| VENLAFAXINE FREE BASE,CONTROL NO.93002023516,MFG.OCTOBER/2016,RE TEST DATE:OCTOBER/2021 |
| SERTRALINE HYDROCHLORIDE PH. EUR. (MICRONISED) |
| SUBSTITUTED HEREROCYCLE /AROMATIC CHEMICAL-METHY-CHLORO-HYDROXYPHENYL-THIENO PYRIDINE CARBOXYLATE |
| CHEMICAL NOT COVERED UNDER SCOMET-IMPURITY/STANDARD OF TICAGRELOR TCG-13-HCL-WEINTEND TO TAKE CHAPTER 3 BENIFIT-QTY 40M |
| CHEMICAL NOT COVERED UNDER SCOMET-MONTELUKAST SODIUM (IMPURITY/STANDARD) <MLK-NAOPTICAL MARKER>-[R,S(E)-1-[[[1-[3-[2-(7 |
| SERTRALINE HYDROCHLORIDE PH.EUR |
| PANTOPRAZOLE SODIUM STERILE ((34% TO 38%W/W)B.NO. APSS16002 MFG: 08/16, EXP: 07/19) |
| ESOMEPRAZOLE SODIUM STERILE ((34% TO 38%W/W)B.NO. AESS16002 MFG. 09/16 & EXP. 08/19) |
| CHEMICAL NOT COVERED UNDER SCOMET-IMPURITY/STANDARD OF CLOPIDOGREL BISULFATE CLD-ACID-WE INTEND TO TAKE CHAPTER 3 BENIFI |
| CHEMICAL NOT COVERED UNDER SCOMET-(IMPURITY/STANDARD OF QUETIAPINE FUMARATE)QUETIAPINE FUMARATE IH STD-WE INTEND TO TAKE |
| CHEMICAL NOT COVERED UNDER SCOMET-IMPURITY STANDARD OF OLMESARTAN MEDOXOMIL-OLM-6 (MTT)-WE INTEND TO TAKE CHAPTER 3 BENI |
| CHEMICAL COMPOUND FOR SYNTHESIS OF SUBSTITUTED HETEROCYCLE/AROMATIC COMPOUND-FLUOROPHENYL-AMINO PRROLO ETC. |
| SERTRALINE HYDROCHLORIDE PH. EUR. (MICRONISED) |
| PHARMACEUTICALS PRODUCTS: STRYCHNINE SULPHATE TABLETS |
| CHEMICAL NOT COVERED UNDER SCOMET-PREGABALIN (IMPURITIES/STANDARD)<S-PRG-LACTAME>-S-(+)-4-ISOBUTYL-PYRROLIDIN-2-ONE-WE I |
| LORATADINE (LRHB 6531,6532 M.NOV-2016E.OCT-2020) |
| LORATADINE (LRHB 6532 M.NOV-2016 E.OCT-2020) |
| PHARMACEUTICALS PRODUCTS: NUX-VOMICA EXTRACT |
| CHEMICAL NOT COVERED UNDER SCOMET-(1 R,3R,4R)-ACETOXY-3-(1 -(TERT-BUTYLDIMETHYLSILYLOXY)ETHYL)-1-(4 -METHOXYPHENYL)-2-AZ |
| OMEPPRAZOLE SODIUM STERILE (B.NO. SI/OPZ/0071016 MFG: 10/16, EXP: 09/19) |
| OMEPRAZOLE SODIUM STERILE (34% TO 38% W/W) |
| 4-((TERT-BUTYLDIMETHYSILYL)OXY)PENT-3-EN-2-ONE BATCH NO.MS/245/00/C279/53MFG.DT:OCT 16 |
| ATORVASTATIN CALCIUM (ATI 6179 M.OCT-2016 E.SEP-2019, ATI 6180,6181,6182,6183,6184,6185 M.NOV-2016 E.OCT-2019) |
| CHEMICAL NOT COVERED UNDER SCOMET-IMPURITY/STANDARD OF LEDIASVIR LPV ACETYL IMPURITY-WE INTEND TO TAKE CHAPTER 3 BENIFIT |
| CHEMICAL NOT COVERED UNDER SCOMET-IMPURITY/STANDARD OF LEDIASVIR LPV FORMYL IMPURITY-WE INTEND TO TAKE CHAPTER 3 BENIFI |
| SERTRALINE HYDROCHLORIDE PH.EUR |
| SUBSTITUTED HETEROCYCLE/AROMATIC CHEMICALS-BIS-DIPHENYLPHOSPHINO-FERROCENE (AS PER INVOICE)(QTY IN VIAL) |